Companies

Oct 26, 2011

US proposals give Big Pharma more power over patents, prices

Leaked documents from the Trans Pacific Partnership (TPP) Agreement negotiations currently under way in Peru show the US is seeking to use the agreement to increase the monopoly rights of pharmaceutical companies, writes Dr Deborah Gleeson, a Research Fellow in the School of Public Health and Human Biosciences at La Trobe University.

Leaked documents from the Trans Pacific Partnership (TPP) Agreement negotiations currently under way in Peru show the US is seeking to use the agreement to increase the monopoly rights of pharmaceutical companies and undermine the effectiveness of pharmaceutical reimbursement programs such as Australia’s Pharmaceutical Benefits Scheme.

1 comments

Leave a comment

One thought on “US proposals give Big Pharma more power over patents, prices

  1. Peter Bayley

    Once upon a time, I would have considered the PBS safe in Labor hands and would have looked forwarded to watching the Australian government prosecute a vigorous defense on its behalf. But those days are gone; Labor has lost its way and has fatally compromised its principles in pursuit of popularism and a move to the chimeric “middle”.

    The people (only a few at the moment) are starting to realise that neither major party actually represents their interests, having essentially sold out to Corporatism (witness the mining “tax”).

    BTW this is the as-yet inarticulate idea behind the Occupy??? movements. Consequently, I see an OccupyBigPharma movement looming in the near future

Share this article with a friend

Just fill out the fields below and we'll send your friend a link to this article along with a message from you.

Your details

Your friend's details

Sending...